Found 6 matching trials
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer PHASE2 Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer PHASE2 To observe the incidence of chemotherapy-induced myelosuppression and the s...
Show More Location
The Affiliated Hospital of Nanjing University Medical School
Learn More & Join Trial
Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma PHASE3 Indication : Adult patients with intermediate low or mid rectal adenocarcin...
Show More Location
Institut Sainte Catherine
Learn More & Join Trial
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. PHASE3 PANThEON is a randomized, open-label, multicenter phase III trial aimed at ...
Show More Location
Centro Di Riferimento Oncologico Di Aviano
Learn More & Join Trial
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma PHASE2 Locally advanced rectal carcinoma raise the issue of both the oncological c...
Show More Location
Institut Paoli Calmettes
Learn More & Join Trial
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer PHASE3 The goal of this study is to determine the safety and efficacy of a chemoth...
Show More Learn More & Join Trial